Algert Global LLC Innoviva, Inc. Transaction History

Algert Global LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $674,844 - $936,864	-47,126 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $725,269 - $954,301	47,126 New	47,126 $912,000
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $124,999 - $152,401	-10,917 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $16,910 - $19,678	-1,529 Reduced 12.29%	10,917 $130,000
Q4 2020 Feb 12, 2021	BUY	$9.33 - $12.48 $116,121 - $155,326	12,446 New	12,446 $154,000
Q4 2018 Feb 01, 2019	SELL	$13.96 - $18.26 $219,269 - $286,809	-15,707 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $2.31 Million - $2.66 Million	-169,327 Reduced 91.51%	15,707 $239,000
Q2 2018 Aug 02, 2018	SELL	$13.44 - $17.59 $944,778 - $1.24 Million	-70,296 Reduced 27.53%	185,034 $2.55 Million
Q1 2018 May 03, 2018	BUY	$13.8 - $16.99 $3.27 Million - $4.02 Million	236,671 Added 1268.4%	255,330 $4.26 Million
Q4 2017 Feb 01, 2018	SELL	$11.73 - $14.75 $649,032 - $816,132	-55,331 Reduced 74.78%	18,659 $265,000
Q3 2017 Nov 17, 2017	BUY	$12.06 - $14.12 $892,319 - $1.04 Million	73,990	73,990 $1.05 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.